Eversept Partners, LP Vertex Pharmaceuticals Inc Transaction History

Eversept Partners, LP

$1.32 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $9.89 Million - $11.1 Million	-54,500 Closed	0 $0
Q2 2021 Nov 08, 2023	BUY	$187.49 - $221.1 $10.2 Million - $12 Million	54,500 New	54,500 $11 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $10.2 Million - $12 Million	54,500 New	54,500 $11 Million
Q1 2020 May 13, 2020	SELL	$199.77 - $247.81 $14.6 Million - $18.1 Million	-73,009 Closed	0 $0
Q4 2019 Nov 08, 2023	BUY	$166.71 - $223.91 $3.68 Million - $4.95 Million	22,100 Added 43.41%	73,009 $16 Million
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $3.68 Million - $4.95 Million	22,100 Added 43.41%	73,009 $16 Million
Q3 2019 Nov 08, 2023	SELL	$166.23 - $187.09 $1.15 Million - $1.3 Million	-6,940 Reduced 12.0%	50,909 $8.63 Million
Q3 2019 Nov 13, 2019	SELL	$166.23 - $187.09 $1.15 Million - $1.3 Million	-6,940 Reduced 12.0%	50,909 $8.63 Million
Q2 2019 Nov 08, 2023	BUY	$164.61 - $190.37 $3.23 Million - $3.74 Million	19,620 Added 51.32%	57,849 $10.6 Million
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $3.23 Million - $3.74 Million	19,620 Added 51.32%	57,849 $10.6 Million
Q1 2019 Nov 08, 2023	BUY	$163.73 - $194.7 $284,399 - $338,193	1,737 Added 4.76%	38,229 $7.03 Million
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $284,399 - $338,193	1,737 Added 4.76%	38,229 $7.03 Million
Q4 2018 Nov 08, 2023	SELL	$151.91 - $192.21 $1.76 Million - $2.23 Million	-11,600 Reduced 24.12%	36,492 $6.05 Million
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $1.76 Million - $2.23 Million	-11,600 Reduced 24.12%	36,492 $6.05 Million
Q3 2018 Nov 08, 2023	BUY	$167.73 - $192.74 $2.23 Million - $2.56 Million	13,270 Added 38.11%	48,092 $9.27 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $2.23 Million - $2.56 Million	13,270 Added 38.11%	48,092 $9.27 Million
Q2 2018 Nov 08, 2023	SELL	$145.72 - $169.96 $1.46 Million - $1.7 Million	-10,000 Reduced 22.31%	34,822 $5.92 Million
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $1.46 Million - $1.7 Million	-10,000 Reduced 22.31%	34,822 $5.92 Million
Q1 2018 Nov 08, 2023	BUY	$151.6 - $177.13 $6.8 Million - $7.94 Million	44,822 New	44,822 $7.31 Billion
Q1 2018 May 14, 2018	SELL	$151.6 - $177.13 $2.02 Million - $2.36 Million	-13,300 Reduced 22.88%	44,822 $7.31 Million
Q4 2017 Nov 08, 2023	BUY	$137.28 - $155.55 $7.98 Million - $9.04 Million	58,122 New	58,122 $8.71 Billion
Q4 2017 Feb 13, 2018	BUY	$137.28 - $155.55 $7.98 Million - $9.04 Million	58,122	58,122 $8.71 Million

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

226M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.8 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.9 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$11 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$6.06 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.41 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $133B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Account